chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Double vision; Taste metallic; Felt a hot searing through her veins; Diarrhea; Rash on her arm; Sore arm; headache; fatigue; lymphedema; lost her vocabulary; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOEDEMA (lymphedema), APHASIA (lost her vocabulary), DIPLOPIA (Double vision), DYSGEUSIA (Taste metallic) and BURNING SENSATION (Felt a hot searing through her veins) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Lymphedema.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced APHASIA (lost her vocabulary). On an unknown date, the patient experienced LYMPHOEDEMA (lymphedema), DIPLOPIA (Double vision), DYSGEUSIA (Taste metallic), BURNING SENSATION (Felt a hot searing through her veins), DIARRHOEA (Diarrhea), RASH (Rash on her arm), PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, LYMPHOEDEMA (lymphedema), APHASIA (lost her vocabulary), DIPLOPIA (Double vision), DYSGEUSIA (Taste metallic), BURNING SENSATION (Felt a hot searing through her veins), DIARRHOEA (Diarrhea), RASH (Rash on her arm), PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
coughing, wheezing, fever, achy, no appetite Mbr is a firefighter, fighting the fires currently in city, tested positive for Covid yesterday and is isolated but temperatures are very cold.  Would like to discuss if he should drive home in his condition.  States that he is describing symptoms as flu like.
Went to hospital ER 5/20/04 pm with fever of 104F Had generalized seizer for 10 min. Admitted to hospital.  Stayed in hospital for 3-4 days.
Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.  On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 22-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19).   At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, COVID-19: negative (Negative) On 18-FEB-2021, patient tested negative for COVID-19.. On 22-Feb-2021, COVID-19: positive (Positive) On 22-FEB-2021, patient tested positive for COVID-19..   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   It is reported that on 23-FEB-2021, patient is scheduled to have antibody infusions.  Concomitant product use was not provided by the reporter. No treatment information was provided.
as the mother of a son that had heart problems right after the first P shot. I'm fortunate that my son is still alive; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient (son).A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number, Expiry date was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization.The patient medical history and concomitant medications were not reported.The patient experienced as the mother of a son that had heart problems right after the first p shot. im fortunate that my son is still alive on an unspecified date, she also posted a link to this video of a father who says he lost his son to an adverse event after receiving the Pfizer. Event took place after use of product. The clinical outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
52 year old female received the Pfizer vaccine on 30 Dec 2020. Noticed a slight left sided facial droop as left lower lip numbess on 31 Dec 2020, which has become more pronounced over the past 2 days. She states she spoke to the nurse hotline right before speaking to me who told her to go to the ED (she was on her way). Denies any extremity weakness, numbness, HA or dizziness. No pain to face or ear. Speech clear on the phone. No recent illness or history of Bell's palsy. NKDA or any prior adverse reactions to immunizations.
Initial case was received on 05 August 2010 from a healthcare professional. A 76 year old male patient received on 12 July 2010 a left tricep subcutaneous injection of YF VAX (lot number UF793AA). On 01 August 2010, the patient experienced "some hearing loss over the weekend." The patient's pre-existing medical conditions included hyperlipidemia and an unspecified cardiac condition. He was taking multiple unspecified medications. It was unknown if the patient was well at the time of the vaccination. However, he was cleared for vaccination by a physician. The patient was to have a hearing test. As of this report, it was unknown if the patient recovered from the hearing loss. Documents held by sender: None.
Slight arm pain day after injection.  On 6/14/21 nausea with abdominal cramps thru the evening with chills. On 6/15 and 6/16 severe diarrhea throughout the day.  Treatment to this point has been maintaining fluids , water, sports drink and pedialyte. Immodiium taken on 6/16 at 5pm
chronic hives break outs along with severe itching Treatments: steroids, Allegra, Famotidine (20mg), Fexofenadine Hydrochloride (180mg)
Sore  armpit on same side as second dose. It is still sore today, 7/22/21, and my second dose was over 3 months ago.
2hr p/vax rash & two red lines across chest x 24hr;sore arm & feeling like a warm wriggling or muscle spasm a few seconds every 3-4hr;
in bed for 2 days; tired; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (in bed for 2 days) and FATIGUE (tired) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient was on a respirator) in 2020. Previously administered products included for Product used for unknown indication: Flu shot (Patient get tired after any vaccine). Past adverse reactions to the above products included Tiredness with Flu shot.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced BEDRIDDEN (in bed for 2 days) and FATIGUE (tired). On 06-Mar-2021, BEDRIDDEN (in bed for 2 days) had resolved. At the time of the report, FATIGUE (tired) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was provided. No treatment medication details was provided.  The patient got the second dose vaccination on 01APR2021.   This case was linked to MOD-2021-360282 (Patient Link).
Lack of energy, tired, swollen lips,tight throat, eyes puffy. Given Benadyrl 25mg at 3:10 PM, noticed improvement at about 3:20 PM. Called Pediatrician.
Lymph node in left axilla became swollen and enlarged right after 2nd dose in primary series and has remained enlarged and tender for 8 months.
Patient had rash since Jan1,2022 all over body.  Itchy and worse at night.  Patient received the vaccine at the pharmacy.  Was seen in Urgent Care  1-4-22, then followed up with our office on 1-11-22.  Was given prednisolone at both places
1/19/21 - 5:00 p.m. started getting chills ... could not get warm, by 8:30 had 3 blankets on trying to get warm ... uncontrollable shivering and shaking ... body aches and pains, bad headache - slept 14 hours ... Wednesday, 1/20/21 - extreme fatigue (may have been from no sleep the night before ),  headache, muscle aches and pain), so much so I had to miss work - which I don't HARDLY every do. Thursday, 1/21/21 - just sore arm still and headache, but much better
Information has been received from a registered nurse concerning an approximately 18 year old female who was vaccinated in her thigh, with a second dose of Gardasil. Three to four weeks post vaccination the patient developed a "quarter size" raised and tender area in the vicinity of the injection site. Unspecified medical attention as sought. On an unspecified date, the patient recovered. Additional information has been requested. This is one of two reports from the same source.
Pt presented 9/26/17 reported a slight swelling in vaccine arm. Hard to discern. Reported using ice after vaccinated. No redness or heat seen
callous rough area at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site induration in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site induration. On an unknown date, the outcome of the injection site induration was unknown.   It was unknown if the reporter considered the injection site induration to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient developed callous rough area at injection site after the receipt of Shingrix in the left arm. The reporter did not consent to follow-up.
Face broke out into rash night of shots, woke up to forehead bleeding rash, scabbed up next day, then left done the same.
Severe headache within 1 hour, chills, 101.9 temp Body ache?s, neck stiffness- cant turn head side to side. Frequently feeling a swoosh of heat coming from my feet to my head. Light headed an dizzy, nauseated an left arm pain
Redness, warmth, painful injection site with swelling. Approximate area 15 cm X 9 cm as of 4/13/16. Injection received on 4/11/16. 4 mg methylprednisolone prescription and 800 mg BACTRIM prescription.
fever; nausea; This is a spontaneous report from a non-contactable reporter (healthcare professional).   A 51-year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date 12Jan2022 (Lot number: FD7218) at the age of 51 year(s) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN;  Lot number: Unknown;  Route of administration: Unspecified.), for COVID-19 immunisation.  The following information was reported: PYREXIA (non-serious) with onset an unknown date in Jan2022, outcome "unknown", described as "fever"; NAUSEA (non-serious) with onset an unknown date in Jan2022, outcome "unknown", described as "nausea".   No follow-up attempts are possible. No further information is expected.
Severe itching, mostly the legs. High fever 102 degrees, Aches and shivering lasting 2 days
01/04/22 presents to EC ED for "fever, myalgias, cough". PMHx of "Multiple Sclerosis on Ocrelizumab, Type 2 DM, Essential HTN, Endometrial CA"
Rash, (itchy), fever. Dx. Zyrtec, Caladryl
little redness and soreness at the injection arm; little redness and soreness at the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (little redness and soreness at the injection arm) and VACCINATION SITE PAIN (little redness and soreness at the injection arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (little redness and soreness at the injection arm) and VACCINATION SITE PAIN (little redness and soreness at the injection arm). At the time of the report, VACCINATION SITE ERYTHEMA (little redness and soreness at the injection arm) and VACCINATION SITE PAIN (little redness and soreness at the injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
1st dose in 2018, didnt receive a 2nd dose; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not applicable to this report. Till the time of reporting the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient asked that will he/she need to repeat the first dose before receiving the booster. The follow-up would not possible as no contact details were available.
Pt. received his vaccines and when he woke up noticed a lump on his (R) thigh. When seen in office, the lump appeared red, itchy, and slightly larger than a quarter, also hot to the touch. Pt. was treated with antibiotics.
1st dose 2June2022, is at office for 2nd; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (received 1st dose on 2nd June 2022).   On an unknown date, the patient did not receive the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 30-AUG-2022 Reporter's comment: The pharmacist reported that the patient was at the office for the second dose of Twinrix. The reporter did not consent to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Twinrix, which led to incomplete course of vaccination.
Scarring of heart; Heavy fatigue; cannot walk; anything like physical activity I can not do; Itching now it is kind of hives; Itching now it is kind of hives; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old male patient received bnt162b2 (BNT162B2), on 05Jan2022 as dose 2, single (Batch/Lot number: unknown) at the age of 29 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: bnt162b2 (Dose 1, single), administration date: 15Dec2021, for COVID-19 immunisation. The following information was reported: FATIGUE (non-serious) with onset 13Feb2022, outcome "not recovered", described as "Heavy fatigue"; PRURITUS (non-serious), URTICARIA (non-serious) all with onset 13Feb2022, outcome "unknown" and all described as "Itching now it is kind of hives"; MYOCARDIAL FIBROSIS (non-serious) with onset 13Feb2022, outcome "unknown", described as "Scarring of heart"; GAIT INABILITY (non-serious) with onset 13Feb2022, outcome "unknown", described as "cannot walk; anything like physical activity I can not do". Therapeutic measures were not taken as a result of myocardial fibrosis, fatigue, gait inability, pruritus, urticaria.  Additional information: Consumer stated, He had a quick question. Yes,  He reported 30 minutes, he was on the phone and he had 30 minutes conversation. He reported a side effects on the Pfizer vaccination. He said he had 30 minute conversation just now and he, phone on the, hello? Okay He had said he had 30 minute conversation. He was making a report on the vaccination (Further not clarified if the caller called in Pfizer Drug Safety, hence captured as initial report in tab), the Pfizer Vaccination He had got side effects on for me and he had, at end of the conversation, He was asking a lady for claim over then she was like, He guess, he did not get one and he was trying to figure out if he was making a report or something and he was trying to follow up and he would had claims number on the report he was making.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Pt started screaming several hrs p/immun; Leg was red & swollen above knee over whole thigh; Pt screamed 3 hrs; Didn't see MD; Talked to MD 1mo later;
This spontaneous report as received from a nurse practitioner refers to a 33 years old male patient with no pertinent medical history and no drug reactions/allergies. The patient was intramuscularly vaccinated with the first dose of GARDASIL (Lot #, dose were unspecified) on 23-MAY-2012. No other co-suspects were reported. No concomitant medications were used. It was reported that the patient was administered the dose in the GARDASIL series on 23-MAY-2012 and "within a couple of hours a red rash appeared on his neck and chest". The patient had sought medical attention via contacting physician via e-mail. No lab diagnostics studies performed. No treatment was given for AE. While the exact date the rash resolved was unknown, the nurse practitioner noted the rash "had resolved by 01-JUN-2012 but may have been earlier". No subsequent doses of GARDASIL had been administered. The outcome was reported as recovered/resolved. Additional has been requested.
Large red circular area at injection site immediately following injection that grew as days went on, lasted about 4 days, eventually bruised then came back a few days later as a red spot. Warm to the touch and hard under the skin. The day after shot, developed hives all over trunk, arms, legs, feet, hands, and back.
Subcutaneous induration & nodule.  Tender to touch - 9cm x 7cm
About 4 minutes, post vax, she had severe itching. Gave Benadryl 50mg po (liquid). Pt became dizzy about 5 minutes later. Laid flat and monitored vital signs and called 911 to site. Pt did return to normal in approx. 15 minutes.
diarrhea; Mild itchy hives on the neck; Sore left arm; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 03Apr2021 at 12:45 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included bronchitis [hospitalization for bronchitis for 10 days at the age of 11 (15 years ago Concomitant medications included norethisterone acetate (NORETHINDRONE) from an unknown date for an unknown indication. The patient previously took Ventolin Evohaler for bronchitis from unknown date to unknown date. (Used Ventolin Evohaler for 6 years after the hospitalization. Over the years, "I have not experienced any breathing issues and stopped using Evohaler completely"). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, after the vaccination, the patient experienced sore left arm for 6 days. On 08Apr2021 at 10:00, the patient experienced mild itchy hives on the neck that was still present on 09Apr2021. On 09Apr2021 in the morning, the patient experienced diarrhea. The patient did not receive any treatment for the events. The clinical outcome of the event sore left arm was recovered on an unknown date in Apr2021 and of the event mild itchy hives on the neck and diarrhea were recovering.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt states couldn't lift arm after about an hour of receiving 3rd dose of Moderna. Pt stated her arm was red and swollen; when you touched the arm, it gave her chills (she stated the chills felt good). She was also experiencing chills at night as well.
Child's arm right warm, hard, red, swollen from shoulder to elbow. No complaint of pain.
Narrative: Patient is a 49 year old man with past medical history of hypertension and kidney stones who presented with a chief complaint of word finding difficulties and slurred speech. Patient was last seen normal at 1230 pm on 1/21/2021. He got his covid vaccine and shortly after he developed a headache that was on both sides of his head. Felt like 8/10 pain. He then had difficulty with speaking - he didn't know what word to say so he would make a noise. He was on the phone, and that person recommended that he come to the ED to get evaluated.In the ED, a stroke code was called. BP 169/97. NIHSS 0. A CT non con did not show any acute bleed or any signs of a stroke. After the stoke code was ended, the patient has a headache severity 1/10 and did not have any word finding difficulties. Patient was non focal by the time that the stroke code was ended. In the setting of hypertension, a blood pressure of 169/97 on admission and fluctuating symptoms, most concerning on the differential is a TIA. Given his risk factors and episodic presentation, he will need to be worked up for a stroke. The differential also includes post-vaccination reaction vs complex migraine.
Patient reports running a fever through the night of the 25th.  She woke up on the 26th no feeling well, took her blood sugar which was 142 mg/dL.  Shortly after she checked her blood sugar she passed out.  Her daughter is a nurse and when she arrived, she checked the patient's blood pressure which was noted to be in the 90s systolic.  Shortly after that a re-check of her blood pressure improved to 117/60 .  Patient was scheduled to be seen with her primary care provider on the 26th to verify that patient was stable.
Redness of eyes, heart racing, itching, tingling around mouth, sore throat, general poor feeling.
I received both covid vaccinations in around February 2021. I then received my booster in November. In September I had a huge increase in eczema. Then in November a few weeks after getting my booster, I began having dermatitis on my hands. Symptoms include redness, swelling, blistering, peeling, cracking and itching. This has gotten worse and persisted until currently. I have been on two different steroid creams and changed my wedding rings from white gold to platinum thinking I may be allergic to gold. The rash is on both hands, but started on my left hand.
Flu symptoms, but most notably the loss of muscle strength in her legs. She collapsed and was unable to walk.
Patient complaints of soreness, tenderness/redness in injection site left arm, started 1 hour after vaccination and then next morning pain spread to muscles left chest.